Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.5 RB, SLActive? 14mm, RXD: medical device reports filed with FDA

864 reports name it, 2020–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

864
device reports naming the brand
0% of all MAUDE reports · about 136 a year
230
reports, 12 months to August 2026
196 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 864 reports that name the brand "BLX ?3.5 RB, SLActive? 14mm, RXD" (endosseous dental implant), received between March 2020 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

230 reports arrived in the 12 months to August 2026, up 17% from 196 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.8%), loss of osseointegration (11%) and difficult to insert (2.2%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02040Sep 2021: 7Oct 2021: 9Nov 2021: 9Dec 2021: 82022Jan 2022: 6Feb 2022: 9Mar 2022: 5Apr 2022: 16May 2022: 14Jun 2022: 7Jul 2022: 7Aug 2022: 13Sep 2022: 2Oct 2022: 24Nov 2022: 6Dec 2022: 152023Jan 2023: 12Feb 2023: 4Mar 2023: 15Apr 2023: 10May 2023: 13Jun 2023: 7Jul 2023: 15Aug 2023: 9Sep 2023: 8Oct 2023: 6Nov 2023: 10Dec 2023: 72024Jan 2024: 10Feb 2024: 12Mar 2024: 7Apr 2024: 19May 2024: 15Jun 2024: 19Jul 2024: 20Aug 2024: 10Sep 2024: 19Oct 2024: 22Nov 2024: 9Dec 2024: 252025Jan 2025: 17Feb 2025: 10Mar 2025: 11Apr 2025: 7May 2025: 0Jun 2025: 40Jul 2025: 14Aug 2025: 22Sep 2025: 15Oct 2025: 14Nov 2025: 14Dec 2025: 112026Jan 2026: 20Feb 2026: 14Mar 2026: 33Apr 2026: 21May 2026: 20Jun 2026: 20Jul 2026: 20Aug 2026: 28

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0941872020: 1420202021: 7220212022: 12420222023: 11620232024: 18720242025: 17520252026: 1762026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%864
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77.9%673
Voluntary report0%0
User facility report0%0
Distributor report22.1%191
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate63873.8%62.8%
Loss of osseointegration9511%22.4%
Difficult to insertthe device was hard to insert192.2%0.4%
Fracturea broken bone70.8%1.6%
Separation failure30.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis23627.3%
Painpain, site not specified14216.4%
Inflammationinflammation414.7%
Swelling/ edema273.1%
Hyperresponsive to stimuli232.7%
Hemorrhage/blood loss/bleeding202.3%
Abscessa collection of pus182.1%
Fistula101.2%
Hypersensitivity/allergic reaction50.6%
Tissue damage50.6%
Numbnessnumbness20.2%
Failure of implant10.1%
Inadequate osseointegration10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.5 RB, SLActive? 14mm, RXDProduct code DZEAll MAUDE reports
Reports8643,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.5 RB, SLActive? 14mm, RXD reports

How many FDA reports name BLX ?3.5 RB, SLActive? 14mm, RXD?

864 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 230 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.8%), loss of osseointegration (11%), difficult to insert (2.2%), fracture (0.8%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77.9%) and distributor reports (22.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.5 RB, SLActive? 14mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.